We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Particle Characterization System Critical to Development of Brain Tumor Illumination

By HospiMedica International staff writers
Posted on 05 Feb 2010
A particle characterization system is proving to be a creative research tool for advanced healthcare applications such as gene therapy and selective-target carrier molecules. More...


The University of Washington (Seattle, WA, USA) researchers reported that accurate zeta potential and particle size measurements were critical to their successful development of fluorescent, tumor-targeting iron oxide nanoparticles. Able to safely cross the blood-brain barrier and selectively illuminate brain cancer cells during a magnetic resonance imaging (MRI) scan, the innovative molecules resulting from this research should make brain cancer imaging much safer.

"Safe molecular penetration of the blood-brain barrier depends on a particle's size, fat content, and electric charge. It wasn't until we obtained the Zetasizer Nano in 2006 that we were able to efficiently measure, monitor, and optimize these properties and develop nanoparticles that deliver the desired half-life in blood but remain stable long enough to support imaging,” explained Prof. Miqin Zhang, from the University of Washington's department of materials science and engineering. The Zetasizer Nano system was developed by Malvern Instruments (Malvern, UK).

The blood-brain barrier protects the brain from infection. Current imaging techniques require the injection of both dyes and a drug to forcefully open the barrier. Prof. Zhang and her team have formulated particles approximately 33 nm in diameter. Three times smaller in wet conditions than anything previously formulated in the lab, these particles can naturally penetrate the blood-brain barrier without exposing the patient to the risk of infection, and represent a highly significant advance in brain cancer imaging.

The Nanoparticle Lab within the University of Washington's department of materials science and engineering focuses its research on cancer diagnosis and treatment through imaging enhancement and targeted and controlled therapeutic payload delivery. This is accomplished by use of nanoconjugates or multifunctional nanovectors. A nanoconjugate is a chemically modified nanoparticle serving as a "vehicle” that carries biomolecules to target cells. The term "nanovector” here refers to a nanosized entity that plays a functional role in the perspective of therapeutics.

Malvern Instruments provides a range of complementary materials characterization tools that deliver interrelated measurements reflecting the complexities of particulates and disperse systems, nanomaterials and macromolecules. Analytic instruments from Malvern are used in the characterization of a wide variety of materials, from industrial bulk powders to nanomaterials and delicate macromolecules. A wide range of innovative technologies is combined with intelligent, user-friendly software. These systems provide industrially relevant data enabling the customers to make the connection between micro (such as particle size) and macro (bulk) material properties (rheology) and chemical composition (chemical imaging).

Particle size, particle shape, zeta potential, molecular weight, chemical composition and rheologic properties measurements are combined by advanced chromatography systems (GPC/SEC), extending Malvern's technologies for protein molecular weight, size, and aggregation measurements, and synthetic polymer molecular weight and distribution.

Related Links:

University of Washington
Malvern Instruments



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Autoclave
Advance
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.